Programmed cell death protein 1 inhibitor

Clinical trials for Programmed cell death protein 1 inhibitor explained in plain language.

Never miss a new study

Get alerted when new Programmed cell death protein 1 inhibitor trials appear

Sign up with your email to follow new studies for Programmed cell death protein 1 inhibitor, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

New bladder cancer cocktail aims to save the bladder

Disease control Ongoing

This phase 2 trial is testing whether a combination of chemotherapy, an immunotherapy drug called toripalimab, and radiation can effectively treat muscle-invasive bladder cancer while allowing patients to keep their bladder. About 71 adults with this type of bladder cancer will r…

Matched conditions: PROGRAMMED CELL DEATH PROTEIN 1 INHIBITOR

Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control

Last updated Jun 27, 2026 08:00 UTC

Programmed cell death protein 1 inhibitor

Get alerted when new Programmed cell death protein 1 inhibitor trials appear

New bladder cancer cocktail aims to save the bladder